IMAX (IMAX) Valuation Check As Exclusive Elvis And Tommy Events Draw Premium Cinema Fans

IMAX (IMAX) is back in the spotlight as it prepares an exclusive theatrical debut for Baz Luhrmann’s Elvis Presley concert documentary, alongside two-day 50th anniversary IMAX screenings of The Who’s rock opera film Tommy.

See our latest analysis for IMAX.

At a share price of US$37.80, IMAX has logged a 6.78% 3 month share price return and a 38.87% 1 year total shareholder return, and recent box office events and premium content partnerships appear to be contributing to gradually building momentum.

If these concert film releases have you thinking about where else premium entertainment and tech could go next, it is a good moment to scan 22 top founder-led companies as potential new ideas.

With IMAX trading at US$37.80 and sitting on a 38.87% 1 year total return, current metrics suggest some valuation support. The real question is whether there is still upside here or if the market is already pricing in future growth.

Most Popular Narrative: 14.3% Undervalued

IMAX's most followed narrative pegs fair value at roughly $44.09, above the recent $37.80 close, framing the current price as leaving room against that estimate.

Diversification of content offerings, including local-language blockbusters, alternative content (concerts, live events), and deeper relationships with streaming and tech partners like Apple, Amazon, and Netflix, is broadening IMAX's audience base and improving margin mix. This is contributing to higher contribution per screen and more resilient earnings.

Read the complete narrative.

Curious what kind of revenue climb, margin shift, and future earnings multiple need to line up to support that fair value story? The full narrative lays out the exact assumptions tying IMAX's premium formats, international footprint, and content pipeline to that $44.09 view.

Result: Fair Value of $44.09 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there is still the risk that weaker cinema attendance or a softer slate of blockbuster releases could pressure IMAX's install pipeline and earnings power.

Find out about the key risks to this IMAX narrative.

Next Steps

If this mix of opportunity and risk leaves you undecided, it may be worth reviewing the numbers yourself and making a decision soon. A good place to start is 3 key rewards.

Looking for more investment ideas?

If IMAX has sparked your interest, do not stop here. Broaden your watchlist with a few targeted stock ideas that could sharpen your next move.

• Start with value using our 53 high quality undervalued stocks to spot companies where pricing and fundamentals may be out of sync.
• Prioritise resilience with the 80 resilient stocks with low risk scores to focus on businesses that score well on stability and risk controls.
• Hunt for future leaders by checking the screener containing 24 high quality undiscovered gems to find quality names that are not yet widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com